NO118229B - - Google Patents
Download PDFInfo
- Publication number
- NO118229B NO118229B NO161305A NO16130566A NO118229B NO 118229 B NO118229 B NO 118229B NO 161305 A NO161305 A NO 161305A NO 16130566 A NO16130566 A NO 16130566A NO 118229 B NO118229 B NO 118229B
- Authority
- NO
- Norway
- Prior art keywords
- virus
- distemper
- tissue
- culture
- vaccine
- Prior art date
Links
- 241000700605 Viruses Species 0.000 claims description 67
- 208000000655 Distemper Diseases 0.000 claims description 57
- 229960005486 vaccine Drugs 0.000 claims description 30
- 210000001519 tissue Anatomy 0.000 claims description 25
- 241000282331 Mustelidae Species 0.000 claims description 13
- 210000003734 kidney Anatomy 0.000 claims description 13
- 230000003053 immunization Effects 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 10
- 241000282465 Canis Species 0.000 claims description 9
- 230000002238 attenuated effect Effects 0.000 claims description 8
- 210000000981 epithelium Anatomy 0.000 claims description 7
- 210000000056 organ Anatomy 0.000 claims description 5
- 238000004113 cell culture Methods 0.000 claims description 3
- 210000004027 cell Anatomy 0.000 description 33
- 239000000243 solution Substances 0.000 description 24
- 235000015097 nutrients Nutrition 0.000 description 20
- 241000282339 Mustela Species 0.000 description 19
- 241000772415 Neovison vison Species 0.000 description 17
- 238000012360 testing method Methods 0.000 description 12
- 239000000725 suspension Substances 0.000 description 11
- 241001465754 Metazoa Species 0.000 description 10
- 239000007921 spray Substances 0.000 description 10
- 210000002966 serum Anatomy 0.000 description 9
- 102000004142 Trypsin Human genes 0.000 description 8
- 108090000631 Trypsin Proteins 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 239000013049 sediment Substances 0.000 description 8
- 239000012588 trypsin Substances 0.000 description 8
- 241000282341 Mustela putorius furo Species 0.000 description 7
- 239000006285 cell suspension Substances 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 238000003306 harvesting Methods 0.000 description 7
- 238000002649 immunization Methods 0.000 description 7
- 238000011081 inoculation Methods 0.000 description 7
- 102000004407 Lactalbumin Human genes 0.000 description 6
- 108090000942 Lactalbumin Proteins 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 6
- 238000010790 dilution Methods 0.000 description 5
- 239000012895 dilution Substances 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 210000003292 kidney cell Anatomy 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 241000282472 Canis lupus familiaris Species 0.000 description 4
- 229930182555 Penicillin Natural products 0.000 description 4
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical group N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 244000309466 calf Species 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 229940049954 penicillin Drugs 0.000 description 4
- 238000002255 vaccination Methods 0.000 description 4
- 108010010803 Gelatin Proteins 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 239000012981 Hank's balanced salt solution Substances 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000012754 cardiac puncture Methods 0.000 description 3
- 230000032823 cell division Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000003472 neutralizing effect Effects 0.000 description 3
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 229960005322 streptomycin Drugs 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 241000879777 Lynx rufus Species 0.000 description 2
- 241000282342 Martes americana Species 0.000 description 2
- 241001508691 Martes zibellina Species 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 239000012531 culture fluid Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000014103 egg white Nutrition 0.000 description 2
- 210000000969 egg white Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 210000005084 renal tissue Anatomy 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- 241000282421 Canidae Species 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 230000010530 Virus Neutralization Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012738 dissolution medium Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 244000144993 groups of animals Species 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000005067 joint tissue Anatomy 0.000 description 1
- 210000000231 kidney cortex Anatomy 0.000 description 1
- 210000000244 kidney pelvis Anatomy 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 239000003104 tissue culture media Substances 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000003934 vacuole Anatomy 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/175—Canine distemper virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEB80160A DE1235505B (de) | 1965-01-19 | 1965-01-19 | Verfahren zur Herstellung einer Vaccine gegen Staupe |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO118229B true NO118229B (cs) | 1969-12-01 |
Family
ID=6980598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO161305A NO118229B (cs) | 1965-01-19 | 1966-01-18 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US3420934A (cs) |
| AT (1) | AT265517B (cs) |
| BE (1) | BE675341A (cs) |
| CA (1) | CA1002878A (cs) |
| CH (1) | CH467861A (cs) |
| DE (1) | DE1235505B (cs) |
| DK (1) | DK113460B (cs) |
| FI (1) | FI42460C (cs) |
| FR (1) | FR1587323A (cs) |
| GB (1) | GB1133958A (cs) |
| LU (1) | LU50203A1 (cs) |
| NL (1) | NL146881B (cs) |
| NO (1) | NO118229B (cs) |
| SE (1) | SE345688B (cs) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE7504610L (sv) * | 1974-04-25 | 1975-10-27 | Inst Poliomielita I Virusnykh | Forfarande for framstellning av en levande odlingsvirusvaccin mot pest hos kottetande djur. |
| DE2921040C2 (de) * | 1979-05-23 | 1984-09-27 | Moskovskij naučno-issledovatel'skij institut virusnych preparatov, Moskva | Lebendimpfstoff zum Immunisieren von fleischfressenden Tieren gegen Staupe und Verfahren zu dessen Herstellung |
| US4554158A (en) * | 1983-04-07 | 1985-11-19 | Simonsen Laboratories, Inc. | Modified live sendai virus vaccine for administering through an aerosol and method of producing the same |
| US4990367A (en) * | 1987-03-09 | 1991-02-05 | Diamond Scientific Company | Canine distemper virus vaccine |
| EP1242117A4 (en) * | 1999-12-28 | 2004-11-17 | Milkhaus Lab Inc | METHOD FOR TREATING SQUARE DISEASE |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3098011A (en) * | 1959-09-03 | 1963-07-16 | Behringwerke Ag | Process of producing a vaccine against distemper |
| DE1138888B (de) * | 1959-09-03 | 1962-10-31 | Behringwerke Ag | Verfahren zur Herstellung einer Vaccine gegen Staupe |
| US3354038A (en) * | 1964-12-02 | 1967-11-21 | Affiliated Lab Corp | Serial passaging tissue cultured canine distemper virus to form attenuated vaccine short of virus-antigenicity decreasing passages |
-
1965
- 1965-01-19 DE DEB80160A patent/DE1235505B/de active Pending
-
1966
- 1966-01-06 LU LU50203D patent/LU50203A1/xx unknown
- 1966-01-07 CH CH56566A patent/CH467861A/de unknown
- 1966-01-11 US US519949A patent/US3420934A/en not_active Expired - Lifetime
- 1966-01-17 AT AT40166A patent/AT265517B/de active
- 1966-01-17 GB GB2088/66A patent/GB1133958A/en not_active Expired
- 1966-01-18 DK DK27566AA patent/DK113460B/da unknown
- 1966-01-18 CA CA950,086A patent/CA1002878A/en not_active Expired
- 1966-01-18 NL NL666600639A patent/NL146881B/xx not_active IP Right Cessation
- 1966-01-18 NO NO161305A patent/NO118229B/no unknown
- 1966-01-19 SE SE674/66A patent/SE345688B/xx unknown
- 1966-01-19 FR FR1587323D patent/FR1587323A/fr not_active Expired
- 1966-01-19 BE BE675341D patent/BE675341A/xx unknown
- 1966-01-19 FI FI660140A patent/FI42460C/fi active
Also Published As
| Publication number | Publication date |
|---|---|
| FI42460B (cs) | 1970-04-30 |
| BE675341A (cs) | 1966-07-19 |
| NL146881B (nl) | 1975-08-15 |
| NL6600639A (cs) | 1966-07-20 |
| CA1002878A (en) | 1977-01-04 |
| AT265517B (de) | 1968-10-10 |
| DK113460B (da) | 1969-03-24 |
| SE345688B (cs) | 1972-06-05 |
| LU50203A1 (cs) | 1967-07-06 |
| DE1235505B (de) | 1967-03-02 |
| US3420934A (en) | 1969-01-07 |
| FR1587323A (cs) | 1970-03-20 |
| FI42460C (fi) | 1970-08-10 |
| CH467861A (de) | 1969-01-31 |
| GB1133958A (en) | 1968-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7351527B2 (en) | Immunizing fish against viral infection | |
| CN107184969A (zh) | 一种a型赛尼卡谷病毒灭活疫苗及其制备方法和应用 | |
| US4224412A (en) | Living virus culture vaccine against canine distemper and method of preparing same | |
| NO159782B (no) | Anordning ved fjaersystem, foerst og fremst paa kjoeretoeyer. | |
| CN1059471A (zh) | 副鸡嗜血杆菌疫苗 | |
| CN111808826B (zh) | 猪A型塞内卡病毒SVA/CH-Fuj株及其应用 | |
| CN109456391A (zh) | 一种预防鹅星状病毒感染的vlp疫苗及其制备方法和应用 | |
| NO118229B (cs) | ||
| IE46498B1 (en) | New vaccine | |
| CN112063596A (zh) | 鸽副黏病毒1型ppmv-1/bj-c株及其应用 | |
| RU2443429C2 (ru) | Вакцина ассоциированная против ньюкаслской болезни птиц, инфекционного бронхита кур, синдрома снижения яйценоскости-76, инфекционной бурсальной болезни и реовирусного теносиновита птиц инактивированная эмульсионная | |
| CN104667269B (zh) | 一种猪流行性腹泻病毒鼻腔免疫疫苗及其制备方法 | |
| US3470294A (en) | Vaccine for immunization of dogs and foxes against distemper,hepatitis contagiosa and leptospirosis and process for preparing it | |
| CN109762062A (zh) | 一种鹅痛风病卵黄抗体的制备方法 | |
| CS199569B2 (en) | Method of producing vaccine against influenza | |
| US3098011A (en) | Process of producing a vaccine against distemper | |
| US3548054A (en) | Method for improving weight gains and reducing gross lesions in chickens exposed to marek's disease | |
| CN108659122B (zh) | 一种防治新型鸡呼肠孤病毒的卵黄抗体及其制备方法 | |
| NO152936B (no) | Fremgangsmaate til fremstilling av et podningsstoff mot panelukopeni i felider | |
| CN113355293B (zh) | 一种小鹅瘟病毒疫苗株、疫苗及基于该疫苗的卵黄抗体 | |
| CN100366291C (zh) | 牛羊等反刍动物口蹄疫o、a型双价灭活疫苗 | |
| JPH08187076A (ja) | 商業的規模の採取前に濃縮された組織培養物が生産する生のＴ．ゴンデイイ（Ｔ．ｇｏｎｄｉｉ）のブラデイゾイト、ならびに製品および方法 | |
| CN108379574B (zh) | 一种防治新型鸡呼肠孤病毒的灭活疫苗及其制备方法 | |
| RU2147892C1 (ru) | Способ получения препарата на основе вирусно-бактериальных штаммов из местного очага для приготовления ассоциированной вакцины или поливалентной гипериммунной сыворотки против заболеваний крупного рогатого скота | |
| RU2154496C2 (ru) | Вакцина против чумы, инфекционного гепатита и парвовирусного энтерита плотоядных |